Kytopen: Funding, Investors & Team (Sep 2026)
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune cells that are typically difficult to manipulate. By utilizing microfluidics and automation, their technology streamlines the process of delivering molecules without the need for viruses, making it more accessible and cost-effective for researchers to develop innovative biological discoveries for cell and gene therapies.
Kytopen has raised $3.6M across 3 funding rounds on record, the most recent a Series B announced in Apr 2026.
Kytopen Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Kytopen Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Kytopen raised $2.0M in an undisclosed round announced in Jun 2021.
3.2 years later, an undisclosed round of $1.6M was announced in Aug 2024.
1.7 years later, a Series B was announced in Apr 2026 with no disclosed amount.
Kytopen Founders and Leadership Team
Contact details for the Kytopen team: 2 of 3 have an email address on file.
Start 14-day free trial →Kytopen Funding Compared to Other Biotechnology Startups
Funded Startups Like Kytopen in Biotechnology and Cambridge
Companies Similar to Kytopen
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Kytopen Funding FAQs
What does Kytopen do?
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune cells that are typically difficult to manipulate. By utilizing microfluidics and automation, their technology streamlines the process of delivering molecules without the need for viruses, making it more accessible and cost-effective for researchers to develop innovative biological discoveries for cell and gene therapies.
How much funding has Kytopen raised?
Kytopen has raised $3.6M across 3 rounds on record.
When did Kytopen last raise funding?
Kytopen's most recent funding round on record was announced in Apr 2026. The amount was not disclosed.
Who founded Kytopen?
FundedIQ lists Michael Chiu (Founder), Paulo Garcia (Founder) at Kytopen.
Who is the CEO of Kytopen?
Paulo A. Garcia is listed as CEO at Kytopen.
Where is Kytopen headquartered?
Kytopen is based in Cambridge, Massachusetts, United States.
How many employees does Kytopen have?
Kytopen is in the 11-50 employee band.
About FundedIQ's Kytopen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kytopen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.